Cover Image

Amoxicillin and Clarithromycin Mucoadhesive Delivery System for <i>Helicobacter pylori</i> Infection in a Mouse Model: Characterization, Pharmacokinetics, and Efficacy

<i>Helicobacter pylori</i> is the main pathogen responsible for gastric ulcers and a predisposing factor of stomach cancer. Although current treatment is usually successful, it requires high doses and frequent administration. An innovative mucoadhesive system (Mucolast<sup>®</su...

Full description

Saved in:

Bibliographic Details
Main Authors:	Isabel Villegas (Author), María Ángeles Rosillo (Author), Catalina Alarcón- (Author), Victoria Vázquez-Román (Author), Maria Llorente (Author), Susana Sánchez (Author), Ana Gloria Gil (Author), Pilar Alcalde (Author), Esther González (Author), Elisabet Rosell (Author), Carles Nieto (Author), Francisco Fernandez-Campos (Author)
Format:	Book
Published:	MDPI AG, 2021-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Transcriptome Analysis of the Response of Mature <i>Helicobacter pylori</i> Biofilm to Different Doses of <i>Lactobacillus salivarius</i> LN12 with Amoxicillin and Clarithromycin
by: Fang Jin, et al.
Published: (2022)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of <i>Helicobacter pylori</i>?
by: Young Min Kim, et al.
Published: (2020)

Genetic Determinants of Clarithromycin and Fluoroquinolones Resistance in <i>Helicobacter pylori</i> in Serbia
by: Dusan Kekic, et al.
Published: (2024)

Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for <i>Helicobacter pylori</i> Therapy
by: David Y. Graham
Published: (2024)

Eradication of Helicobacter pylori with triple therapy regimen (omeprazole, clarithromycin and amoxicillin) in children for seven days (A Pilot Study)
by: Mehri Najafi, et al.
Published: (2014)

Eradication of Helicobacter pylori with triple therapy regimen (omeprazole, clarithromycin and amoxicillin) in children for seven days (A Pilot Study)
by: Mehri Najafi, et al.
Published: (2014)

Novel Mutations Conferring Amoxicillin Resistance in <i>Helicobacter pylori</i> in South Korea
by: Soon Young Park, et al.
Published: (2023)

Pattern of Primary Resistance of <i>Helicobacter pylori</i> to Clarithromycin among Pediatric Patients from North-Eastern Romania
by: Oana-Maria Rosu, et al.
Published: (2023)

Primary resistance to clarithromycin, metronidazole and amoxicillin of <it>Helicobacter pylori </it>isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study
by: Ben Mansour Khansa, et al.
Published: (2010)

Development of a High-Resolution Melting Method for the Detection of Clarithromycin-Resistant <i>Helicobacter pylori</i> in the Gastric Microbiome
by: Zupeng Kuang, et al.
Published: (2024)

Scope and Limitations of Current Antibiotic Therapies against <i>Helicobacter pylori</i>: Reviewing Amoxicillin Gastroretentive Formulations
by: Roberto Grosso, et al.
Published: (2022)

Antibiotic Susceptibility and Clarithromycin Resistance Determinants in <i>Helicobacter pylori</i> in the Northeast of Spain: A One-Year Prospective Study
by: Saray Mormeneo Bayo, et al.
Published: (2023)

Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection
by: Aliakbar Hajiaghamohammadi, et al.
Published: (2016)

Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis
by: Yuko Morino, et al.
Published: (2021)

Enhanced Antibacterial Potential of Amoxicillin against <i>Helicobacter pylori</i> Mediated by Lactobionic Acid Coated Zn-MOFs
by: Haseena, et al.
Published: (2021)

Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for <i>Helicobacter pylori</i> Eradication in the Clinical Setting
by: Seokin Kang, et al.
Published: (2021)

<i>Helicobacter pylori</i> Primary and Secondary Genotypic Resistance to Clarithromycin and Levofloxacin Detection in Stools: A 4-Year Scenario in Southern Italy
by: Giuseppe Losurdo, et al.
Published: (2020)

The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
by: Abbas Arj, et al.
Published: (2020)

Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for <i>Helicobacter pylori</i> Eradication in High Clarithromycin Resistance Areas
by: Sotirios D. Georgopoulos, et al.
Published: (2024)

The Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for <i>Helicobacter pylori</i> Infection: A Systematic Review and Network Meta-Analysis
by: Ligang Liu, et al.
Published: (2023)

Design of Mucoadhesive Nanostructured Polyelectrolyte Complexes Based on Chitosan and Hypromellose Phthalate for Metronidazole Delivery Intended to the Treatment of <i>Helicobacter pylori</i> Infections
by: Maurício Palmeira Chaves de Souza, et al.
Published: (2020)

Mutations in the 23S rRNA gene are associated with clarithromycin resistance in <it>Helicobacter pylori </it>isolates in Brazil
by: Godoy Anita PO, et al.
Published: (2003)

Whole Genome Sequencing for Studying <i>Helicobacter pylori</i> Antimicrobial Resistance
by: Belén Fernández-Caso, et al.
Published: (2023)

<i>Helicobacter pylori</i> Infections in Children
by: Julie Nguyen, et al.
Published: (2023)

Development of Gastroretentive Floating Combination Tablets Containing Amoxicillin Trihydrate 500 mg and Levofloxacin 125 mg for Eradicating Resistant <i>Helicobacter pylori</i>
by: Da Hun Kim, et al.
Published: (2024)

Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis
by: Ebrahim Kouhsari, et al.
Published: (2022)

Efficacy of Bismuth-based Quadruple Therapy as First-line Treatment for Clarithromycin-resistant Helicobacter pylori Infection
by: Seung In Seo, et al.
Published: (2022)

Efficacy of Phenotype-vs. Genotype-Guided Therapy Based on Clarithromycin Resistance for Helicobacter pylori Infection in Children
by: Yan Feng, et al.
Published: (2022)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
by: Min Niu, et al.
Published: (2022)

Development and Optimization of Amoxicillin Floating Raft System to effectively treat Helicobacter pylori infection
by: Akhil Kamsali, et al.
Published: (2020)

Vonoprazan-amoxicillin combination therapy for Helicobacter pylori eradication: an umbrella review of meta-analyses
by: Saif Syed, et al.
Published: (2024)

Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans.
by: Emma Sáez-López, et al.
Published: (2024)

Association of <i> Helicobacter pylori</i> with lichen planus
by: Moravvej Hamideh, et al.
Published: (2007)

Alopecia areata is not associated with <i> Helicobacter pylori</i>
by: Abdel Hafez Hisham, et al.
Published: (2009)

Treatment of Pediatric <i>Helicobacter pylori</i> Infection
by: Hung-Hsiang Lai, et al.
Published: (2022)

Optimal First-line Eradication Regimens for Helicobacter pylori Infection in Patients with Clarithromycin Resistance: A Pilot Study
by: Min Woo Seo, et al.
Published: (2018)

Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children
by: Karam-Ali Kasiri, et al.
Published: (2017)

Antibiotic Resistance and Therapy for <i>Helicobacter pylori</i> Infection
by: Stella I. Smith, et al.
Published: (2023)

Personalized Approach in Eradication of <i>Helicobacter pylori</i> Infection
by: Antonio Mestrovic, et al.
Published: (2022)

Molecular Mechanisms of Biofilm Formation in <i>Helicobacter pylori</i>
by: Kartika Afrida Fauzia, et al.
Published: (2024)